Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市场风起云涌和不确定时期，即使市场处于历史最高点，许多投资者也会转向股息率高的股票。这些公司通常具有高自由现金流并以高股息派息回报股东。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的读者可以查看我们的分析师股票评级页面，查看最新的分析师对他们最喜爱的股票的看法。交易员可以浏览Benzinga的广泛分析师评级数据库，包括按分析师准确性排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是医疗保健板块三只高收益股票最准确的分析师评级。
Royalty Pharma plc (NASDAQ:RPRX)
罗伊尔蒂制药股份有限公司（NASDAQ：RPRX）
- Dividend Yield: 3.06%
- B of A Securities analyst Geoff Meacham maintained a Buy rating and cut the price target from $40 to $38 on April 12. This analyst has an accuracy rate of 64%.
- JP Morgan analyst Chris Schott maintained an Overweight rating and slashed the price target from $45 to $42 on Feb. 20. This analyst has an accuracy rate of 62%.
- Recent News: On June 3, Royalty Pharma priced offering of $1.5 billion of senior unsecured notes.
- Benzinga Pro's real-time newsfeed alerted to latest Royalty Pharma news
- 股息率：3.06%
- 4月12日，美银证券分析师杰夫·米查姆（Geoff Meacham）维持买入评级，将目标价从40美元下调至38美元。该分析师的准确率为64%。
- 2月20日，JP摩根分析师克里斯·肖特（Chris Schott）维持超配评级，将目标价从45美元下调至42美元。该分析师的准确率为62%。
- 近期资讯：6月3日，罗伊尔蒂制药定价15亿美元的优先无抵押票据发行。
- Benzinga Pro的实时新闻提醒了最新的罗伊尔蒂制药资讯。
Johnson & Johnson (NYSE:JNJ)
强生公司（纽交所股票代码：JNJ）
- Dividend Yield: 3.38%
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on May 6. This analyst has an accuracy rate of 68%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $168 to $167 on April 17. This analyst has an accuracy rate of 70%.
- Recent News: Johnson & Johnson is scheduled to host a conference call for investors on Wednesday, July 17 to review second-quarter results.
- Benzinga Pro's charting tool helped identify the trend in Johnson & Johnson's stock.
- 股息率：3.38%
- 5月6日，康泰菲兹杰布·路易斯·陈（Louise Chen）分析师重申超配评级，目标价为215美元。该分析师的准确率为68%。
- 4月17日，摩根士丹利分析师特伦斯·弗林（Terence Flynn）维持等权评级，将目标价从168美元下调至167美元。该分析师的准确率为70%。
- 近期资讯：强生公司定于7月17日星期三为投资者举行电话会议，审查第二季度业绩。
- Benzinga Pro的图表工具有助于识别强生股票的趋势。
Medtronic plc (NYSE:MDT)
美敦力（MDT）公司（纽交所MDT）
- Dividend Yield: 3.42%
- Wells Fargo analyst Larry Biegelsen maintained an Overweight rating and increased the price target from $102 to $105 on May 24. This analyst has an accuracy rate of 71%.
- Truist Securities analyst Richard Newitter maintained a Hold rating and cut the price target from $90 to $88 on May 24. This analyst has an accuracy rate of 74%.
- Recent News: Medtronic, last week, initiated a recall for some versions of its StealthStation S8 application.
- Benzinga Pro's signals feature notified of a potential breakout in Medtronic's shares.
- 股息率：3.42%
- 5月24日，富国银行分析师拉里·比格尔森（Larry Biegelsen）保持超配评级，并将目标价从102美元上调至105美元。该分析师的准确率为71%。
- 5月24日，Truist Securities分析师理查德·纽维特（Richard Newitter）维持持有评级，并将目标价从90美元下调至88美元。该分析师的准确率为74%。
- 近期资讯：上周美敦力公司启动了对其StealthStation S8应用程序某些版本的召回。
- Benzinga Pro的信号特征提示了美敦力股票可能出现突破。
